Dr. Öğr. Üyesi AHMET CİNGÖZ

1. Genetically engineered human cell-based microrobots for selective cancer cell death

SCIENCE ADVANCES , cilt.12, sa.18, ss.1-15, 2026 (SCI-Expanded, Scopus)

2. Distinct transcription factor interactions drive HOXB13 activity in different stages of prostate cancer

NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA. PROCEEDINGS , cilt.122, sa.49, ss.1-12, 2025 (SCI-Expanded, Scopus)

3. Chromatin-focused genetic and chemical screens identify BRPF1 as a targetable vulnerability in Taxol-resistant triple-negative breast cancer

Cingöz A.

EXPERIMENTAL AND MOLECULAR MEDICINE , cilt.0, sa.0, ss.1, 2025 (SCI-Expanded)

4. Functional Genomic Screens Reveal RBBP4 as a Key Regulator of Cell Cycle Progression in TMZ-Resistant Glioblastoma

Cingoz A.

bioRxiv , cilt.0, sa.0, 2025 (Hakemsiz Dergi)

5. Lymphatic vessels accompanying dorsal and basal dural sinuses in the human brain

Cavdar S., Kose B., Altinoz D., Soyler G., Cingoz A., Gurses I. A., et al.

JOURNAL OF CHEMICAL NEUROANATOMY , cilt.134, 2023 (SCI-Expanded, Scopus)

6. Epigenetic-focused CRISPR/Cas9 screen identifies (absent, small, or homeotic)2-like protein (ASH2L) as a regulator of glioblastoma cell survival

Ozyerli-Goknar E., Kala E. Y., Aksu A. C., Bulut I., Cingöz A., Nizamuddin S., et al.

Cell Communication and Signaling , cilt.21, sa.1, 2023 (SCI-Expanded, Scopus)

7. Directing chemiluminescent dioxetanes to mitochondria: A cationic luminophore enables in vitro and in vivo detection of cancer cells upon enzymatic activation

Gunduz H., Acari A., Cetin S., Almammadov T., Pinarbasi-Degirmenci N., Dirak M., et al.

SENSORS AND ACTUATORS B-CHEMICAL , cilt.383, 2023 (SCI-Expanded, Scopus)

8. EPIKOL, a chromatin-focused CRISPR/Cas9-based screening platform, to identify cancer-specific epigenetic vulnerabilities

Yedier-Bayram O., Gokbayrak B., Kayabolen A., Aksu A. C., Cavga A. D., Cingoz A., et al.

CELL DEATH & DISEASE , cilt.13, sa.8, 2022 (SCI-Expanded, Scopus)

9. Parameters Influencing Gene Delivery Efficiency of PEGylated Chitosan Nanoparticles: Experimental and Modeling Approach

Dogan N. O., Bozuyuk U., Erkoc P., Karacakol A. C., Cingoz A., Seker-Polat F., et al.

ADVANCED NANOBIOMED RESEARCH , cilt.2, sa.1, 2022 (ESCI, Scopus)

10. Generation of TRAIL-resistant cell line models reveals distinct adaptive mechanisms for acquired resistance and re-sensitization

Cingoz A., Ozyerli-Goknar E., Morova T., Seker-Polat F., Esai Selvan M., Gumus Z. H., et al.

ONCOGENE , cilt.40, sa.18, ss.3201-3216, 2021 (SCI-Expanded, Scopus)

11. Drug Repositioning Screen on a New Primary Cell Line Identifies Potent Therapeutics for Glioblastoma

Senbabaoglu F., Aksu A. C., Cingoz A., Seker-Polat F., Borklu-Yucel E., Solaroglu I., et al.

FRONTIERS IN NEUROSCIENCE , cilt.14, 2020 (SCI-Expanded, Scopus)

12. Systematic characterization of chromatin modifying enzymes identifies KDM3B as a critical regulator in castration resistant prostate cancer

Sarac H., Morova T., Pires E., McCullagh J., Kaplan A., Cingoz A., et al.

ONCOGENE , cilt.39, sa.10, ss.2187-2201, 2020 (SCI-Expanded, Scopus)

13. TRAIL-conjugated silver nanoparticles sensitize glioblastoma cells to TRAIL by regulating CHK1 in the DNA repair pathway

Sur-Erdem I., Muslu K., Pinarbasi N., Altunbek M., Seker-Polat F., Cingoz A., et al.

NEUROLOGICAL RESEARCH , cilt.42, sa.12, ss.1061-1069, 2020 (SCI-Expanded, Scopus)

14. The fungal metabolite chaetocin is a sensitizer for pro-apoptotic therapies in glioblastoma

Ozyerli-Goknar E., Sur-Erdem I., Seker F., Cingoz A., Kayabolen A., Kahya-Yesil Z., et al.

CELL DEATH & DISEASE , cilt.10, 2019 (SCI-Expanded, Scopus)

15. The pro-apoptotic Bcl-2 family member Harakiri (HRK) induces cell death in glioblastoma multiforme

Kaya-Aksoy E., Cingoz A., Senbabaoglu F., Seker F., Sur-Erdem I., Kayabolen A., et al.

CELL DEATH DISCOVERY , cilt.5, 2019 (SCI-Expanded, Scopus)

16. **Identification of SERPINE1 as a Regulator of Glioblastoma Cell Dispersal with Transcriptome Profiling**

Seker F., Cingoz A., Sur-Erdem I., Erguder N., Erkent A., Uyulur F., et al.

CANCERS , cilt.11, sa.11, 2019 (SCI-Expanded, Scopus)

17. Investigation of the effects of histone deacetylase inhibitors (HDACi) on apoptotic pathway in glioblastoma multiforme (GBM)

Elmas L., CİNGÖZ A., Senbabaoglu F., Secme M., Dodurga Y., Bagci-Onder T., et al.

FEBS OPEN BIO , ss.340-341, 2018 (SCI-Expanded, Scopus)

18. KDM2B, an H3K36-specific demethylase, regulates apoptotic response of GBM cells to TRAIL

Kurt I. C., Sur I., Kaya E., Cingoz A., Kazancioglu S., Kahya Z., et al.

CELL DEATH & DISEASE , cilt.8, 2017 (SCI-Expanded, Scopus)

19. Quinacrine Mediated Sensitization of Glioblastoma (GBM) Cells to TRAIL through MMP-Sensitive PEG Hydrogel Carriers

Erkoc P., Cingoz A., Onder T. B., Kizilel S.

MACROMOLECULAR BIOSCIENCE , cilt.17, sa.2, 2017 (SCI-Expanded, Scopus)

20. An exploration of plastic deformation dependence of cell viability and adhesion in metallic implant materials

Uzer B., Toker S. M., Cingoz A., Bagci-Onder T., Gerstein G., Maier H. J., et al.

JOURNAL OF THE MECHANICAL BEHAVIOR OF BIOMEDICAL MATERIALS , cilt.60, ss.177-186, 2016 (SCI-Expanded, Scopus)

21. Identification of Mitoxantrone as a TRAIL-sensitizing agent for Glioblastoma Multiforme

Senbabaoglu F., Cingoz A., Kaya E., Kazancioglu S., Lack N. A., Acilan C., et al.

CANCER BIOLOGY & THERAPY , cilt.17, sa.5, ss.546-557, 2016 (SCI-Expanded, Scopus)

Dr. Öğr. Üyesi AHMET CİNGÖZ

Yayınlar & Eserler

1. Genetically engineered human cell-based microrobots for selective cancer cell death

2. Distinct transcription factor interactions drive HOXB13 activity in different stages of prostate cancer

3. Chromatin-focused genetic and chemical screens identify BRPF1 as a targetable vulnerability in Taxol-resistant triple-negative breast cancer

4. Functional Genomic Screens Reveal RBBP4 as a Key Regulator of Cell Cycle Progression in TMZ-Resistant Glioblastoma

5. Lymphatic vessels accompanying dorsal and basal dural sinuses in the human brain

6. Epigenetic-focused CRISPR/Cas9 screen identifies (absent, small, or homeotic)2-like protein (ASH2L) as a regulator of glioblastoma cell survival

7. Directing chemiluminescent dioxetanes to mitochondria: A cationic luminophore enables in vitro and in vivo detection of cancer cells upon enzymatic activation

8. EPIKOL, a chromatin-focused CRISPR/Cas9-based screening platform, to identify cancer-specific epigenetic vulnerabilities

9. Parameters Influencing Gene Delivery Efficiency of PEGylated Chitosan Nanoparticles: Experimental and Modeling Approach

10. Generation of TRAIL-resistant cell line models reveals distinct adaptive mechanisms for acquired resistance and re-sensitization

11. Drug Repositioning Screen on a New Primary Cell Line Identifies Potent Therapeutics for Glioblastoma

12. Systematic characterization of chromatin modifying enzymes identifies KDM3B as a critical regulator in castration resistant prostate cancer

13. TRAIL-conjugated silver nanoparticles sensitize glioblastoma cells to TRAIL by regulating CHK1 in the DNA repair pathway

14. The fungal metabolite chaetocin is a sensitizer for pro-apoptotic therapies in glioblastoma

15. The pro-apoptotic Bcl-2 family member Harakiri (HRK) induces cell death in glioblastoma multiforme

16. **Identification of SERPINE1 as a Regulator of Glioblastoma Cell Dispersal with Transcriptome Profiling**

17. Investigation of the effects of histone deacetylase inhibitors (HDACi) on apoptotic pathway in glioblastoma multiforme (GBM)

18. KDM2B, an H3K36-specific demethylase, regulates apoptotic response of GBM cells to TRAIL

19. Quinacrine Mediated Sensitization of Glioblastoma (GBM) Cells to TRAIL through MMP-Sensitive PEG Hydrogel Carriers

20. An exploration of plastic deformation dependence of cell viability and adhesion in metallic implant materials

21. Identification of Mitoxantrone as a TRAIL-sensitizing agent for Glioblastoma Multiforme

Yayın

Yayın (WoS)

Yayın (Scopus)

Atıf (WoS)

H-İndeks (WoS)

Atıf (Scopus)

H-İndeks (Scopus)

Atıf (Scholar)

H-İndeks (Scholar)

Proje

Açık Erişim